Upcoming Education Opportunities
Latest Updates
ECTRIMS 2026
This year IPMSSG meeting will be held jointly with The Sumaira Foundation (TSF). The event will be f…
Comparative Effectiveness of Treatments for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
In this large, prospective, multicenter pediatric MOGAD cohort, IVIG was the only treatment consiste…
MRI Characteristics of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
See the full text here: https://pubmed.ncbi.nlm.nih.gov/42804180/
De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD
In this review, the Authors assess the current evidence, make clinical considerations, and propose f…
Acute Attack Treatment Escalation and Subsequent Relapse Risk in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
In this study, the Authors found that acute immunotherapy escalation was associated with lower early…
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability
In this multicenter study the Authors evaluated long-term disability in patients with pediatric-onse…